Weight-loss drug supplies in Australia are set to improve dramatically as the company behind Ozempic prepares to sell its version of the medication that is specifically designed for patients seeking to shed kilograms.
Drugmaker Novo Nordisk’s decision to finally launch its powerful Wegovy medication in Australia resolves the prospect of a supply disaster in October, when chemist-made versions of Ozempic will be banned.
Loading...
Nick Bonyhady is a technology writer for the Australian Financial Review, based in Sydney. He is a former technology editor, industrial relations and politics reporter at the Sydney Morning Herald and Age. Connect with Nick on Twitter. Email Nick at nick.bonyhady@afr.com
